NCT01373060View on ClinicalTrials.gov

A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of ASP1941 in Healthy Male Taiwanese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
HealthyPharmacokinetics of ASP1941
Interventions
DRUG

ASP1941

oral

DRUG

Placebo

oral

Trial Locations (1)

Unknown

Taipei

Sponsors
All Listed Sponsors
collaborator

Astellas Pharma Taiwan, Inc.

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY